Cloning and characterization of the proximal murine Phex promoter.

Phex is an endopetidase that regulates systemic phosphate homeostasis. We investigated Phex gene transcription by cloning and performing functional analysis of the 2736 bp of the 5' flanking region of the mouse Phex gene containing its promoter. We identified a transcription start site, a consensus TATA-box, and multiple potential cis-acting regulator elements. To determine whether the promoter directs cell-type restricted Phex expression, we transfected full-length and 5'-deleted Phex luciferase reporter constructs into various cell lines. Phex-expressing C5.18 chondrocytes displayed the highest activity of the transfected Phex promoter constructs compared with non-Phex-expressing COS-7 cells, whereas promoter activity was intermediate in ROS 17/2.8 osteoblasts and maturation stage-dependent in MC3T3-E1 osteoblasts. Analysis of sequential 5'-deletion mutants of the Phex promoter in ROS 17/2.8 cells revealed bimodal activity, suggesting that both positive and negative cis-acting regions may be present. The chondrogenic factor SOX9 markedly stimulated Phex promoter activity, whereas Cbfa1, PTH, and 1,25(OH)(2)D(3) had no effect. Our findings are consistent with the predominant expression of Phex in bone and cartilage. Additional studies will be needed to confirm the regulatory regions in the Phex promoter that function in a cell-restricted manner.

[1]  V. Harley,et al.  The DNA-binding specificity of SOX9 and other SOX proteins. , 1999, Nucleic acids research.

[2]  R. Hromas,et al.  Characterization of the DNA-binding properties of the myeloid zinc finger protein MZF1: two independent DNA-binding domains recognize two DNA consensus sequences with a common G-rich core , 1994, Molecular and cellular biology.

[3]  J. Priess,et al.  Formation of a monomeric DNA binding domain by Skn-1 bZIP and homeodomain elements. , 1994, Science.

[4]  T. Meitinger,et al.  Genomic organization of the human PEX gene mutated in X-linked dominant hypophosphatemic rickets. , 1997, Genome research.

[5]  L. Quarles,et al.  Cbfa1 isoform overexpression upregulates osteocalcin gene expression in non‐osteoblastic and pre‐osteoblastic cells , 1999, Journal of cellular biochemistry.

[6]  L. Quarles,et al.  Cloning and Sequencing of Human PEX from a Bone cDNA Library: Evidence for Its Developmental Stage‐Specific Regulation in Osteoblasts , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[7]  J. Downing,et al.  Identification of AML-1 and the (8;21) translocation protein (AML-1/ETO) as sequence-specific DNA-binding proteins: the runt homology domain is required for DNA binding and protein-protein interactions , 1993, Molecular and cellular biology.

[8]  G. Church,et al.  B lineage--specific interactions of an immunoglobulin enhancer with cellular factors in vivo. , 1985, Science.

[9]  I. Boros,et al.  Transcription factor AP-4 participates in activation of bovine leukemia virus long terminal repeat by p34 Tax. , 1994, Nucleic acids research.

[10]  J. Aubin,et al.  Effects of dexamethasone and vitamin D3 on cartilage differentiation in a clonal chondrogenic cell population. , 1989, Endocrinology.

[11]  L. Quarles,et al.  Intrinsic mineralization defect in Hyp mouse osteoblasts. , 1998, American journal of physiology. Endocrinology and metabolism.

[12]  S. Orkin,et al.  DNA-binding specificity of GATA family transcription factors , 1993, Molecular and cellular biology.

[13]  R J Schwartz,et al.  Identification of Novel DNA Binding Targets and Regulatory Domains of a Murine Tinman Homeodomain Factor, nkx-2.5(*) , 1995, The Journal of Biological Chemistry.

[14]  H. Burtscher,et al.  The Transcription Factor Sox9 Is Involved in BMP‐2 Signaling , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[15]  Makoto Sato,et al.  Targeted Disruption of Cbfa1 Results in a Complete Lack of Bone Formation owing to Maturational Arrest of Osteoblasts , 1997, Cell.

[16]  Véronique Lefebvre,et al.  A new long form of Sox5 (L‐Sox5), Sox6 and Sox9 are coexpressed in chondrogenesis and cooperatively activate the type II collagen gene , 1998, The EMBO journal.

[17]  F. Glorieux,et al.  Defective bone formation by hyp mouse bone cells transplanted into normal mice: Evidence in favor of an intrinsic osteoblast defect , 1992, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[18]  R. Lovell-Badge,et al.  Sex‐reversing mutations affect the architecture of SRY‐DNA complexes. , 1994, The EMBO journal.

[19]  J. Collins,et al.  Molecular cloning of the murine PHEX gene promoter. , 2000, Biochimica et biophysica acta.

[20]  P. Goodyer,et al.  PHEX expression in parathyroid gland and parathyroid hormone dysregulation in X-linked hypophosphatemia , 1999, Pediatric Nephrology.

[21]  K. Hruska,et al.  X-linked hypophosphatemic rickets and the murine Hyp homologue. , 1995, The American journal of physiology.

[22]  R. Tjian,et al.  Enhancer binding factors AP-4 and AP-1 act in concert to activate SV40 late transcription in vitro , 1988, Nature.

[23]  P N Goodfellow,et al.  SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha1(II) collagen gene , 1997, Molecular and cellular biology.

[24]  M. Econs,et al.  Phosphate transport in immortalized cell cultures from the renal proximal tubule of normal and Hyp Mice: Evidence That the HYP gene locus product is an extrarenal factor , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[25]  T. Rabbitts,et al.  The LIM‐only protein Lmo2 is a bridging molecule assembling an erythroid, DNA‐binding complex which includes the TAL1, E47, GATA‐1 and Ldb1/NLI proteins , 1997, The EMBO journal.

[26]  L. Quarles,et al.  Developmental regulation of osteocalcin expression in MC3T3‐E1 osteoblasts: Minimal role of the proximal E‐box cis‐acting promoter elements , 1997, Journal of cellular biochemistry.

[27]  A. Poustka,et al.  A gene (PEX) with homologies to endopeptidases is mutated in patients with X–linked hypophosphatemic rickets , 1995, Nature Genetics.

[28]  D. Ambrosetti,et al.  Synergistic activation of the fibroblast growth factor 4 enhancer by Sox2 and Oct-3 depends on protein-protein interactions facilitated by a specific spatial arrangement of factor binding sites , 1997, Molecular and cellular biology.

[29]  S. Ruben,et al.  Selection of optimal kappa B/Rel DNA-binding motifs: interaction of both subunits of NF-kappa B with DNA is required for transcriptional activation , 1992, Molecular and cellular biology.

[30]  Hiroyuki Tanaka,et al.  The Effects of Bone Marrow Transplantation on X‐linked Hypophosphatemic Mice , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[31]  A. Sinclair,et al.  A male-specific role for SOX9 in vertebrate sex determination. , 1996, Development.

[32]  C. Goodyer,et al.  Pex/PEX tissue distribution and evidence for a deletion in the 3' region of the Pex gene in X-linked hypophosphatemic mice. , 1997, The Journal of clinical investigation.

[33]  B. Frenkel,et al.  A composite intragenic silencer domain exhibits negative and positive transcriptional control of the bone-specific osteocalcin gene: promoter and cell type requirements. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[34]  P. Milos,et al.  A ubiquitous factor is required for C/EBP-related proteins to form stable transcription complexes on an albumin promoter segment in vitro. , 1992, Genes & development.

[35]  J. Drouin,et al.  Glucocorticoid receptor binding to a specific DNA sequence is required for hormone-dependent repression of pro-opiomelanocortin gene transcription , 1989, Molecular and cellular biology.

[36]  J. Hartle,et al.  A Distinct Cation‐Sensing Mechanism in MC3T3‐E1 Osteoblasts Functionally Related to the Calcium Receptor , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[37]  M. Lipman,et al.  Cloning of Human PEX cDNA , 1998, The Journal of Biological Chemistry.

[38]  Y. Nabeshima,et al.  The delta-crystallin enhancer-binding protein delta EF1 is a repressor of E2-box-mediated gene activation , 1994, Molecular and cellular biology.

[39]  R. Mantovani,et al.  A survey of 178 NF-Y binding CCAAT boxes. , 1998, Nucleic acids research.

[40]  R. Griffiths,et al.  Crosstransplantation of kidneys in normal and Hyp mice. Evidence that the Hyp mouse phenotype is unrelated to an intrinsic renal defect. , 1992, The Journal of clinical investigation.

[41]  K. Mikoshiba,et al.  Core promoter of the mouse myelin basic protein gene governs brain‐specific transcription in vitro. , 1990, The EMBO journal.

[42]  B. Ecarot,et al.  1,25-(OH)2D3 down-regulates expression of Phex, a marker of the mature osteoblast. , 1999, Endocrinology.